☰

Agata M. Bogusz, Ph.D. - Publications

Affiliations: 
2006 University of Chicago, Chicago, IL 
Area:
Cell Biology, Molecular Biology, Pathology
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhang Q, Orlando E, Wang H, Bogusz AM, Liu X, Lacey SF, Strauser HT, Nunez-Cruz S, Nejati R, Zhang P, Brooks S, Watt C, Melenhorst JJ, June CH, Schuster SJ, et al. Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of epigenome. Blood. PMID 32518951 DOI: 10.1182/Blood.2020005123  0.334
2020 Svoboda J, Bair SM, Landsburg DJ, Nasta SD, Nagle SJ, Barta SK, Khan N, Filicko-O'Hara J, Gaballa S, Strelec L, Chong E, Mitnick S, Waite TS, King C, Ballard H, ... ... Bogusz AM, et al. Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. Haematologica. PMID 32414850 DOI: 10.3324/Haematol.2019.238675  0.381
2019 Qian L, Soderquist C, Schrank-Hacker A, Strauser H, Dupoux V, Tang CN, Smith JR, Sun A, Majumdar S, Nguyen T, Widura S, Landsburg DJ, Schuster SJ, Baxter RHG, Bogusz AM. Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma. American Journal of Hematology. PMID 31804739 DOI: 10.1002/Ajh.25694  0.4
2019 Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein PS, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia. PMID 31758088 DOI: 10.1038/S41375-019-0650-2  0.335
2019 Baraban E, Sadigh S, Rosenbaum J, Van Arnam J, Bogusz AM, Mehr C, Bagg A. Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease. British Journal of Haematology. PMID 31172509 DOI: 10.1111/Bjh.16006  0.386
2019 Landsburg DJ, Hughes ME, Koike A, Bond D, Maddocks KJ, Guo L, Winter AM, Hill BT, Ondrejka SL, Hsi ED, Nasta SD, Svoboda J, Schuster SJ, Bogusz AM. Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. Blood Advances. 3: 132-135. PMID 30651281 DOI: 10.1182/Bloodadvances.2018026401  0.424
2018 Devins K, Schuster SJ, Caponetti GC, Bogusz AM. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation. Diagnostic Pathology. 13: 92. PMID 30470245 DOI: 10.1186/S13000-018-0765-1  0.391
2018 Landsburg DJ, Hughes ME, Koike A, Bond DA, Maddocks KJ, Guo L, Winter AM, Hill BT, Ondrejka SL, Hsi ED, Dwivedy Nasta S, Svoboda J, Schuster SJ, Bogusz AM. Outcomes of Patients with Relapsed/Refractory Double Expressor B Cell Lymphoma As Defined By Multicenter Pathology Review Treated with Ibrutinib Monotherapy Blood. 132: 455-455. DOI: 10.1182/Blood-2018-99-117514  0.365
2018 Svoboda J, Bair SM, Steidl C, Ruella M, Landsburg DJ, Dwivedy Nasta S, Barta SK, Nejati MR, Gerson JN, Strelec LE, Youngman MR, Chong EA, Kutovaya O, Hung S, Bogusz AM, et al. Primary Mediastinal B-Cell Lymphoma: Evaluation of Clinicopathologic Diagnosis Compared to Gene Expression Based Diagnosis in a Clinical Trial with CD30+ B-Cell Lymphomas Blood. 132: 2959-2959. DOI: 10.1182/Blood-2018-99-115024  0.394
2017 Bogusz AM. EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53. Case Reports in Hematology. 2017: 5083463. PMID 28487787 DOI: 10.1155/2017/5083463  0.391
2017 Bogusz AM, Kovach AE, Le LP, Feng D, Baxter RH, Sohani AR. Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence. Plos One. 12: e0172364. PMID 28212447 DOI: 10.1371/Journal.Pone.0172364  0.413
2017 Svoboda J, Landsburg DJ, Nasta SD, Barta SK, Khan N, Fung HC, Tan CR, Filicko-O'Hara J, Gaballa S, Strelec LE, Nagle SJ, Bair SM, Mitnick S, Waite TS, Sargent RL, ... Bogusz AM, et al. Brentuximab Vedotin with R-CHP Chemotherapy As Frontline Treatment for Patients with CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, and Grey Zone Lymphomas: Results of a Phase I/II Multisite Trial Blood. 130: 191-191. DOI: 10.1182/Blood.V130.Suppl_1.191.191  0.342
2016 Hatem J, Schrank-Hacker AM, Watt CD, Morrissette JJ, Rubin AI, Kim EJ, Nasta SD, Wasik MA, Bogusz AM. Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report. Diagnostic Pathology. 11: 137. PMID 27993143 DOI: 10.1186/S13000-016-0588-X  0.442
2016 Hatem J, Bogusz AM. An Unusual Case of Extranodal Diffuse Large B-Cell Lymphoma Infiltrating Skeletal Muscle: A Case Report and Review of the Literature. Case Reports in Pathology. 2016: 9104839. PMID 27247818 DOI: 10.1155/2016/9104839  0.389
2016 Bogusz AM, Bagg A. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets. Leukemia & Lymphoma. 1-23. PMID 27121112 DOI: 10.3109/10428194.2016.1173212  0.423
2013 Aljinovic N, Bogusz AM, Kantarci S, Buck TP, Dewar R. An unusual case of Philadelphia chromosome-positive chronic myelogenous leukemia with trisomy 19 presenting with megakaryoblastosis and myelofibrosis. Archives of Pathology & Laboratory Medicine. 137: 1147-51. PMID 23899072 DOI: 10.5858/Arpa.2012-0151-Cr  0.368
2013 Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D, Doench JG, Bogusz AM, Habermann TM, Dogan A, Witzig TE, Kutok JL, Rodig SJ, Golub T, Shipp MA. SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell. 23: 826-38. PMID 23764004 DOI: 10.1016/J.Ccr.2013.05.002  0.395
2013 Bogusz AM, Tierno B, Brown D, Pihan G. Extreme signet ring cell change in a large B-cell lymphoma of follicular origin. International Journal of Surgical Pathology. 21: 399-403. PMID 23364357 DOI: 10.1177/1066896912474342  0.391
2013 Bogusz AM, Bhargava P. Recurrent histiocytic necrotizing lymphadenitis with a long latency in a patient with autoimmunity: a case report and review of literature. International Journal of Surgical Pathology. 21: 287-96. PMID 23204033 DOI: 10.1177/1066896912467369  0.329
2012 Bogusz AM, Baxter RH, Currie T, Sinha P, Sohani AR, Kutok JL, Rodig SJ. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6122-35. PMID 22966017 DOI: 10.1158/1078-0432.Ccr-12-0397  0.413
2011 Bogusz AM, Hussey SM, Kapur P, Peng Y, Gokaslan ST. Massive localized lymphedema with unusual presentations: report of 2 cases and review of the literature. International Journal of Surgical Pathology. 19: 212-6. PMID 18611926 DOI: 10.1177/1066896908320833  0.319
2009 Bogusz AM, Seegmiller AC, Garcia R, Shang P, Ashfaq R, Chen W. Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. American Journal of Clinical Pathology. 132: 597-605. PMID 19762538 DOI: 10.1309/Ajcpfur1Bk0Uodts  0.379
2006 Bogusz AM, Brickley DR, Pew T, Conzen SD. A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway. The Febs Journal. 273: 2913-28. PMID 16817852 DOI: 10.1111/J.1742-4658.2006.05304.X  0.485
Show low-probability matches.